Cargando…

Performance on a probabilistic inference task in healthy subjects receiving ketamine compared with patients with schizophrenia

Evidence suggests that some aspects of schizophrenia can be induced in healthy volunteers through acute administration of the non-competitive NMDA-receptor antagonist, ketamine. In probabilistic inference tasks, patients with schizophrenia have been shown to ‘jump to conclusions’ (JTC) when asked to...

Descripción completa

Detalles Bibliográficos
Autores principales: Evans, Simon, Almahdi, Basil, Sultan, Pervez, Sohanpal, Imrat, Brandner, Brigitta, Collier, Tracey, Shergill, Sukhi S, Cregg, Roman, Averbeck, Bruno B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546628/
https://www.ncbi.nlm.nih.gov/pubmed/22389244
http://dx.doi.org/10.1177/0269881111435252
_version_ 1782256076921503744
author Evans, Simon
Almahdi, Basil
Sultan, Pervez
Sohanpal, Imrat
Brandner, Brigitta
Collier, Tracey
Shergill, Sukhi S
Cregg, Roman
Averbeck, Bruno B
author_facet Evans, Simon
Almahdi, Basil
Sultan, Pervez
Sohanpal, Imrat
Brandner, Brigitta
Collier, Tracey
Shergill, Sukhi S
Cregg, Roman
Averbeck, Bruno B
author_sort Evans, Simon
collection PubMed
description Evidence suggests that some aspects of schizophrenia can be induced in healthy volunteers through acute administration of the non-competitive NMDA-receptor antagonist, ketamine. In probabilistic inference tasks, patients with schizophrenia have been shown to ‘jump to conclusions’ (JTC) when asked to make a decision. We aimed to test whether healthy participants receiving ketamine would adopt a JTC response pattern resembling that of patients. The paradigmatic task used to investigate JTC has been the ‘urn’ task, where participants are shown a sequence of beads drawn from one of two ‘urns’, each containing coloured beads in different proportions. Participants make a decision when they think they know the urn from which beads are being drawn. We compared performance on the urn task between controls receiving acute ketamine or placebo with that of patients with schizophrenia and another group of controls matched to the patient group. Patients were shown to exhibit a JTC response pattern relative to their matched controls, whereas JTC was not evident in controls receiving ketamine relative to placebo. Ketamine does not appear to promote JTC in healthy controls, suggesting that ketamine does not affect probabilistic inferences.
format Online
Article
Text
id pubmed-3546628
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-35466282013-01-28 Performance on a probabilistic inference task in healthy subjects receiving ketamine compared with patients with schizophrenia Evans, Simon Almahdi, Basil Sultan, Pervez Sohanpal, Imrat Brandner, Brigitta Collier, Tracey Shergill, Sukhi S Cregg, Roman Averbeck, Bruno B J Psychopharmacol Original Papers Evidence suggests that some aspects of schizophrenia can be induced in healthy volunteers through acute administration of the non-competitive NMDA-receptor antagonist, ketamine. In probabilistic inference tasks, patients with schizophrenia have been shown to ‘jump to conclusions’ (JTC) when asked to make a decision. We aimed to test whether healthy participants receiving ketamine would adopt a JTC response pattern resembling that of patients. The paradigmatic task used to investigate JTC has been the ‘urn’ task, where participants are shown a sequence of beads drawn from one of two ‘urns’, each containing coloured beads in different proportions. Participants make a decision when they think they know the urn from which beads are being drawn. We compared performance on the urn task between controls receiving acute ketamine or placebo with that of patients with schizophrenia and another group of controls matched to the patient group. Patients were shown to exhibit a JTC response pattern relative to their matched controls, whereas JTC was not evident in controls receiving ketamine relative to placebo. Ketamine does not appear to promote JTC in healthy controls, suggesting that ketamine does not affect probabilistic inferences. SAGE Publications 2012-09 /pmc/articles/PMC3546628/ /pubmed/22389244 http://dx.doi.org/10.1177/0269881111435252 Text en © The Author(s) 2012 http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Papers
Evans, Simon
Almahdi, Basil
Sultan, Pervez
Sohanpal, Imrat
Brandner, Brigitta
Collier, Tracey
Shergill, Sukhi S
Cregg, Roman
Averbeck, Bruno B
Performance on a probabilistic inference task in healthy subjects receiving ketamine compared with patients with schizophrenia
title Performance on a probabilistic inference task in healthy subjects receiving ketamine compared with patients with schizophrenia
title_full Performance on a probabilistic inference task in healthy subjects receiving ketamine compared with patients with schizophrenia
title_fullStr Performance on a probabilistic inference task in healthy subjects receiving ketamine compared with patients with schizophrenia
title_full_unstemmed Performance on a probabilistic inference task in healthy subjects receiving ketamine compared with patients with schizophrenia
title_short Performance on a probabilistic inference task in healthy subjects receiving ketamine compared with patients with schizophrenia
title_sort performance on a probabilistic inference task in healthy subjects receiving ketamine compared with patients with schizophrenia
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546628/
https://www.ncbi.nlm.nih.gov/pubmed/22389244
http://dx.doi.org/10.1177/0269881111435252
work_keys_str_mv AT evanssimon performanceonaprobabilisticinferencetaskinhealthysubjectsreceivingketaminecomparedwithpatientswithschizophrenia
AT almahdibasil performanceonaprobabilisticinferencetaskinhealthysubjectsreceivingketaminecomparedwithpatientswithschizophrenia
AT sultanpervez performanceonaprobabilisticinferencetaskinhealthysubjectsreceivingketaminecomparedwithpatientswithschizophrenia
AT sohanpalimrat performanceonaprobabilisticinferencetaskinhealthysubjectsreceivingketaminecomparedwithpatientswithschizophrenia
AT brandnerbrigitta performanceonaprobabilisticinferencetaskinhealthysubjectsreceivingketaminecomparedwithpatientswithschizophrenia
AT colliertracey performanceonaprobabilisticinferencetaskinhealthysubjectsreceivingketaminecomparedwithpatientswithschizophrenia
AT shergillsukhis performanceonaprobabilisticinferencetaskinhealthysubjectsreceivingketaminecomparedwithpatientswithschizophrenia
AT creggroman performanceonaprobabilisticinferencetaskinhealthysubjectsreceivingketaminecomparedwithpatientswithschizophrenia
AT averbeckbrunob performanceonaprobabilisticinferencetaskinhealthysubjectsreceivingketaminecomparedwithpatientswithschizophrenia